Fighting Liver Cancer Takes Big Financial Toll: Study
THURSDAY, Feb. 2, 2023 (HealthDay News) — Out-of-pocket costs can leave Medicare patients with the most common type of liver cancer in financial distress. While Medicare payments in the first year after diagnosis with hepatocellular carcinoma (HCC) exceeded $65,000, out-of-pocket costs were more than $10,000, a new study found. “AsContinue Reading